Weiwei Chen1, Susan A Gauthier, Ajay Gupta, Joseph Comunale, Tian Liu, Shuai Wang, Mengchao Pei, David Pitt, Yi Wang. 1. From the Department of Radiology, Tongji Hospital, Tongji Medical College, Huazhong University of Science & Technology, Wuhan, China (W.C.); Departments of Neurology (S.A.G.) and Radiology (W.C., A.G., J.C., T.L., S.W., M.P., Y.W.), Weill Cornell Medical College, 515 E 71st St, New York, NY 10021; Department of Biomedical Engineering, Cornell University, Ithaca, NY (T.L., Y.W.); Department of Biomedical Engineering, Kyung Hee University, Seoul, South Korea (Y.W.); School of Electronic Engineering, University of Electronic Science and Technology of China, Chengdu, China (S.W.); and Department of Neurology, Yale University, New Haven, Conn (D.P.).
Abstract
PURPOSE: To assess multiple sclerosis (MS) lesions at various ages by using quantitative susceptibility mapping (QSM) and conventional magnetic resonance (MR) imaging. MATERIALS AND METHODS: Retrospectively selected were 32 clinically confirmed MS patients (nine men and 23 women; 39.3 years ± 10.9) who underwent two MR examinations (interval, 0.43 years ± 0.16) with three-dimensional gradient-echo sequence from August 2011 to August 2012. To estimate the ages of MS lesions, MR examinations performed 0.3-10.6 years before study examinations were studied. Hyperintensity on T2-weighted images was used to define MS lesions. QSM images were reconstructed from gradient-echo data. Susceptibility of MS lesions and temporal rates of change were obtained from QSM images. Lesion susceptibilities were analyzed by t test with intracluster correlation adjustment and Bonferroni correction in multiple comparisons. RESULTS: MR imaging of 32 patients depicted 598 MS lesions, of which 162 lesions (27.1%) in 23 patients were age measurable and six (1.0%) were only visible at QSM. The susceptibilities relative to normal-appearing white matter (NAWM) were 0.53 ppb ± 3.34 for acute enhanced lesions, 38.43 ppb ± 13.0 (positive; P < .01) for early to intermediately aged nonenhanced lesions, and 4.67 ppb ± 3.18 for chronic nonenhanced lesions. Temporal rates of susceptibility changes relative to cerebrospinal fluid were 12.49 ppb/month ± 3.15 for acute enhanced lesions, 1.27 ppb/month ± 2.31 for early to intermediately aged nonenhanced lesions, and -0.004 ppb/month ± 0 for chronic nonenhanced lesions. CONCLUSION: Magnetic susceptibility of MS lesions increased rapidly as it changed from enhanced to nonenhanced, it attained a high susceptibility value relative to NAWM during its initial few years (approximately 4 years), and it gradually dissipated back to susceptibility similar to that of NAWM as it aged, which may provide new insight into pathophysiologic features of MS lesions. Online supplemental material is available for this article. RSNA, 2013
PURPOSE: To assess multiple sclerosis (MS) lesions at various ages by using quantitative susceptibility mapping (QSM) and conventional magnetic resonance (MR) imaging. MATERIALS AND METHODS: Retrospectively selected were 32 clinically confirmed MS patients (nine men and 23 women; 39.3 years ± 10.9) who underwent two MR examinations (interval, 0.43 years ± 0.16) with three-dimensional gradient-echo sequence from August 2011 to August 2012. To estimate the ages of MS lesions, MR examinations performed 0.3-10.6 years before study examinations were studied. Hyperintensity on T2-weighted images was used to define MS lesions. QSM images were reconstructed from gradient-echo data. Susceptibility of MS lesions and temporal rates of change were obtained from QSM images. Lesion susceptibilities were analyzed by t test with intracluster correlation adjustment and Bonferroni correction in multiple comparisons. RESULTS: MR imaging of 32 patients depicted 598 MS lesions, of which 162 lesions (27.1%) in 23 patients were age measurable and six (1.0%) were only visible at QSM. The susceptibilities relative to normal-appearing white matter (NAWM) were 0.53 ppb ± 3.34 for acute enhanced lesions, 38.43 ppb ± 13.0 (positive; P < .01) for early to intermediately aged nonenhanced lesions, and 4.67 ppb ± 3.18 for chronic nonenhanced lesions. Temporal rates of susceptibility changes relative to cerebrospinal fluid were 12.49 ppb/month ± 3.15 for acute enhanced lesions, 1.27 ppb/month ± 2.31 for early to intermediately aged nonenhanced lesions, and -0.004 ppb/month ± 0 for chronic nonenhanced lesions. CONCLUSION: Magnetic susceptibility of MS lesions increased rapidly as it changed from enhanced to nonenhanced, it attained a high susceptibility value relative to NAWM during its initial few years (approximately 4 years), and it gradually dissipated back to susceptibility similar to that of NAWM as it aged, which may provide new insight into pathophysiologic features of MS lesions. Online supplemental material is available for this article. RSNA, 2013
Authors: Wei Bian; Kristin Harter; Kathryn E Hammond-Rosenbluth; Janine M Lupo; Duan Xu; Douglas Ac Kelley; Daniel B Vigneron; Sarah J Nelson; Daniel Pelletier Journal: Mult Scler Date: 2012-05-28 Impact factor: 6.312
Authors: Tian Liu; Jing Liu; Ludovic de Rochefort; Pascal Spincemaille; Ildar Khalidov; James Robert Ledoux; Yi Wang Journal: Magn Reson Med Date: 2011-04-04 Impact factor: 4.668
Authors: C A Habib; M Liu; N Bawany; J Garbern; I Krumbein; H-J Mentzel; J Reichenbach; C Magnano; R Zivadinov; E M Haacke Journal: AJNR Am J Neuroradiol Date: 2011-11-24 Impact factor: 3.825
Authors: Dmitriy A Yablonskiy; Jie Luo; Alexander L Sukstanskii; Aditi Iyer; Anne H Cross Journal: Proc Natl Acad Sci U S A Date: 2012-08-13 Impact factor: 11.205
Authors: Amir Eissa; R Marc Lebel; Jeff R Korzan; Anna E Zavodni; Kenneth G Warren; Ingrid Catz; Derek J Emery; Alan H Wilman Journal: J Magn Reson Imaging Date: 2009-10 Impact factor: 4.813
Authors: Bing Yao; Tie-Qiang Li; Peter van Gelderen; Karin Shmueli; Jacco A de Zwart; Jeff H Duyn Journal: Neuroimage Date: 2008-11-05 Impact factor: 6.556
Authors: Christian Enzinger; Frederik Barkhof; Olga Ciccarelli; Massimo Filippi; Ludwig Kappos; Maria A Rocca; Stefan Ropele; Àlex Rovira; Torben Schneider; Nicola de Stefano; Hugo Vrenken; Claudia Wheeler-Kingshott; Jens Wuerfel; Franz Fazekas Journal: Nat Rev Neurol Date: 2015-11-03 Impact factor: 42.937
Authors: M Castellaro; R Magliozzi; A Palombit; M Pitteri; E Silvestri; V Camera; S Montemezzi; F B Pizzini; A Bertoldo; R Reynolds; S Monaco; M Calabrese Journal: AJNR Am J Neuroradiol Date: 2017-04-13 Impact factor: 3.825
Authors: Jinwei Zhang; Zhe Liu; Shun Zhang; Hang Zhang; Pascal Spincemaille; Thanh D Nguyen; Mert R Sabuncu; Yi Wang Journal: Neuroimage Date: 2020-01-22 Impact factor: 6.556
Authors: Ulrike W Kaunzner; Yeona Kang; Shun Zhang; Eric Morris; Yihao Yao; Sneha Pandya; Sandra M Hurtado Rua; Calvin Park; Kelly M Gillen; Thanh D Nguyen; Yi Wang; David Pitt; Susan A Gauthier Journal: Brain Date: 2019-01-01 Impact factor: 13.501
Authors: Zhe Liu; Yan Wen; Pascal Spincemaille; Shun Zhang; Yihao Yao; Thanh D Nguyen; Yi Wang Journal: Magn Reson Med Date: 2019-08-11 Impact factor: 4.668